Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin – preliminary results

INTRODUCTION: This study determines prognostic factors in patients with advanced urothelial cancer (UC) treated with gemcitabine-cisplatin or carboplatin (GC). MATERIAL AND METHODS: The clinical records of 30 patients with advanced UC treated with GC were retrospectively reviewed. Twenty-six patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Morizane, Shuichi, Iwamoto, Hideto, Yao, Akihisa, Isoyama, Tadahiro, Sejima, Takehiro, Takenaka, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2012
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921783/
https://www.ncbi.nlm.nih.gov/pubmed/24578930
http://dx.doi.org/10.5173/ceju.2012.02.art1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921783/
https://www.ncbi.nlm.nih.gov/pubmed/24578930
http://dx.doi.org/10.5173/ceju.2012.02.art1

Ejemplares similares